Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer

Authors not listed

SCRI Development Innovations, LLC · 2002

Abstract

In this phase II trial, we will evaluate the weekly schedule of topotecan in the first-line treatment of elderly and/or poor performance status patients with extensive stage small cell lung cancer. Patients eligible for this trial will be those considered poor candidates for standard combination chemotherapy or other investigational regimens

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Anonymous. (2002). Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer. <em>SCRI Development Innovations, LLC</em>. https://clinicaltrials.gov/study/NCT00193401
Vancouver
Anonymous. Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer. SCRI Development Innovations, LLC. 2002.
BibTeX
@misc{anon2002PhaseI, title = {Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer}, author = {Anonymous}, journal = {SCRI Development Innovations, LLC}, year = {2002}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings